Prostate Cancer - Results from #25820

Thirty years of research on infection and prostate cancer: No conclusive evidence for a link. A systematic review - Abstract May 23, 2012

Intraductal carcinoma of the prostate - Abstract May 23, 2012

Implications of the International Society of Urological Pathology modified Gleason grading system - Abstract May 23, 2012

Using circulating tumor cells as a prognostic indicator in metastatic castration-resistant prostate cancer - Abstract May 23, 2012

Brachytherapy for prostate cancer does not influence long-term depression rate - Abstract May 23, 2012

Review: Psychosocial interventions addressing sexual or relationship functioning in men with prostate cancer - Abstract May 23, 2012

AUA 2012 - Perspectives from the AUA - PSA controversy: Do the harms exceed the benefits or the benefits exceed the harms? - A take-away message for urologists May 23, 2012

AUA 2012 - Using social media to gauge reaction to the United States Preventive Services Task Force’s (USPSTF) report: Twitter as an investigative tool - Session Highlights May 23, 2012

AUA 2012 - Prostate cancer diagnosis in patients receiving unrelated urologic care: Overdiagnosis or appropriate care? - Poster May 23, 2012

AUA 2012 - Male pattern baldness may be a predictor of prostate cancer - Press Release May 23, 2012

AUA 2012 - Evidence suggests statin use may slow prostate growth - Press Release May 23, 2012

Quality of life in men receiving radiotherapy and neo-adjuvant androgen deprivation for prostate cancer: Results from a prospective longitudinal study - Abstract May 22, 2012

AUA 2012 - Androgen biosynthesis inhibition and metastatic castration-resistant prostate cancer - Exclusive Interview May 22, 2012

Long-term oncological outcome and risk stratification in men with high-risk prostate cancer treated with radical prostatectomy - Abstract May 22, 2012

The efficacy and safety of degarelix, a GnRH antagonist: A 12-month, multicentre, randomized, maintenance dose-finding Phase II study in Japanese patients with prostate cancer - Abstract May 22, 2012

AUA 2012 - Group seminars are an effective and economic method of delivering patient information regarding radical prostatectomy and functional outcomes - Session Highlights May 22, 2012

AUA 2012 - The changing "landscape" of clinical T3 prostate cancer - Session Highlights May 22, 2012

AUA 2012 - Abiraterone acetate (an androgen biosynthesis inhibitor) in patients with metastatic castration-resistant prostate cancer - Slide Presentation May 22, 2012

AUA 2012 - Differences In perioperative outcomes between African American and Caucasian patients after radical prostatectomy - Session Highlights May 22, 2012

AUA 2012 - Understanding and sequencing abiraterone acetate in patients with metastatic castration-resistant prostate cancer - Exclusive Podcast May 22, 2012

Page 1292 of 1437